2
Views
5
CrossRef citations to date
0
Altmetric
WILSON'S DISEASE

Wilson's disease

Psychiatric manifestations may be the clinical presentation

Pages 135-138 | Published online: 05 Dec 2017

References

  • Walker S 3d. The psychiatric presentation of Wilson's disease (hepatolenticular degeneration) with an etiologic explanation. Behav Neuropsychiatry 1969; 1(8): 38–43
  • Dening TR, Berrios GE. Wilson's disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989; 46(12): 1126–34
  • Gilroy J, Meyer JS. Medical neurology. 3d ed. New York: Macmillan, 1979: 297–8
  • Walshe JM. The physiology of copper in man and its relation to Wilson's disease. Brain 1967; 90(1): 149–76
  • Williams FJ, Walshe JM. Wilson's disease: an analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. Brain 1981; 104(4): 735–52
  • Scheinberg IH, Sternlieb I, Richman J. Psychiatric manifestations in patients with Wilson's disease. Birth Defects 1968; 4(2): 85
  • Dening TR, Berrios GE, Walshe JM. Wilson's disease and epilepsy. Brain 1988; 111(5): 1139–55
  • Kanski JJ. Clinical ophthalmology: a systematic approach. 2d ed. Stoneham, Mass: Butterworth, 1989
  • Inose T. Neuropsychiatric manifestations in Wilson's disease: attacks of disturbance of consciousness. Birth Defects 1968; 4(2): 74
  • Wilson SA. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912; 39(Mar): 296–509
  • Knehr CA, Beam AG. Psychological impairment in Wilson's disease. J Nerv Ment Dis 1956; 124(3): 251–5
  • Beard AW. The association of hepatolenticular degeneration with schizophrenia. Acta Psychiatr Scand 1959; 34(1): 411–28
  • Walshe JM. Penicillamine: a new oral therapy for Wilson's disease. Am J Med 1956; 21(Oct): 487–95
  • Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982; 1 (Mar 20): 643–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.